Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Public Health

Attributes and Predictors of Long-COVID

by Global Biodefense Staff
October 24, 2020
Attributes and Predictors of Long-COVID

Photo by TamWai / Unsplash

Long-COVID is characterized by symptoms of fatigue, headache, dyspnoea and anosmia. At the population level, it is critical to quantify the burden of Long-COVID to better assess its impact on the healthcare system and appropriately distribute resources.

A new study led by researchers from King’s College London suggests Long-COVID affects around 10% of 18-to 49-year-olds following infection with SARS-CoV-2. The study found the syndrome was more likely with increasing age, body mass index (BMI) and female sex.

The scientists analyzed data from 4182 incident cases of self-logged symptoms in the COVID Symptom Study app.

The researchers also found that experiencing more than five symptoms during the first week of illness was associated with Long-COVID.

The method underscored in the study could help determine at-risk groups and could be used to target early intervention trials of treatment and and clinical service developments to support rehabilitation to alleviate Long-COVID.

This paper is a medRxiv pre-print still undergoing peer-review

Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. October 21, 2020. https://doi.org/10.1101/2020.10.19.20214494

Tags: COVID-19Editor PickEpidemiologyMedicine-HealthSARS-CoV-2

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC